Variant report

Variant	esv3370382
Chromosome Location	chr10:21614396-21616344
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 121 )
Associated
traits (count: 35 )

Variant overlapped rSNPs/rCNVs (count:121 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs138586863	chr10:21614403-21614404	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs544913555	chr10:21614407-21614408	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs181897356	chr10:21614425-21614426	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs560188190	chr10:21614464-21614465	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs184880465	chr10:21614475-21614476	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs112675744	chr10:21614477-21614478	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs372406007	chr10:21614518-21614519	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs183124793	chr10:21614525-21614526	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs148913203	chr10:21614557-21614558	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs144076736	chr10:21614563-21614564	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs548570662	chr10:21614567-21614568	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs568505146	chr10:21614580-21614581	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs527763537	chr10:21614601-21614602	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs547623331	chr10:21614606-21614607	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs143581455	chr10:21614607-21614608	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs148087749	chr10:21614647-21614648	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs370325182	chr10:21614648-21614649	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs569986542	chr10:21614687-21614688	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs533909340	chr10:21614757-21614758	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs370941114	chr10:21614828-21614829	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs36133057	chr10:21614830-21614831	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs112247199	chr10:21614834-21614835	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs191741773	chr10:21614842-21614843	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs376285521	chr10:21614844-21614845	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs74207291	chr10:21614854-21614855	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs112305726	chr10:21614855-21614856	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs183196260	chr10:21614875-21614876	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs372550609	chr10:21614886-21614887	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs374299572	chr10:21614893-21614894	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs375583728	chr10:21614901-21614902	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs369437860	chr10:21614907-21614908	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs373438089	chr10:21614923-21614924	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs535760580	chr10:21614960-21614961	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs74198341	chr10:21614972-21614973	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs74202576	chr10:21614998-21614999	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs12782382	chr10:21615001-21615002	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs367893700	chr10:21615008-21615009	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs74214354	chr10:21615009-21615010	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs371767353	chr10:21615011-21615012	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs12782406	chr10:21615041-21615042	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs187854678	chr10:21615066-21615067	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs12360010	chr10:21615081-21615082	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs36130967	chr10:21615082-21615083	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs12360369	chr10:21615088-21615089	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs375306698	chr10:21615119-21615120	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs375350095	chr10:21615127-21615128	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs572641051	chr10:21615136-21615137	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs369066090	chr10:21615142-21615143	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs367647428	chr10:21615148-21615149	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs372604501	chr10:21615153-21615154	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:35)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Intracranial aneurysm	16715129	CNVD
Multiple myeloma	16616336	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
small cell lung cancer	20016488	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21364760	CNVD
Glioblastoma multiforme	21525872	CNVD

Chromatin state (count:30 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:21607800-21615800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
2	chr10:21608000-21619000	Weak transcription	Lung	lung
3	chr10:21608800-21615800	Weak transcription	A549	lung
4	chr10:21612800-21616000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
5	chr10:21615800-21616200	Enhancers	Placenta	Placenta
6	chr10:21615800-21616400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
7	chr10:21615800-21616400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr10:21615800-21616400	Enhancers	A549	lung
9	chr10:21615800-21616600	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr10:21615800-21616600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr10:21615800-21616600	Enhancers	HUES48 Cell Line	embryonic stem cell
12	chr10:21615800-21616600	Enhancers	iPS-18 Cell Line	embryonic stem cell
13	chr10:21615800-21616800	Enhancers	H1 Cell Line	embryonic stem cell
14	chr10:21615800-21616800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr10:21615800-21616800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
16	chr10:21615800-21616800	Enhancers	HUES6 Cell Line	embryonic stem cell
17	chr10:21615800-21616800	Enhancers	Placenta Amnion	Placenta Amnion
18	chr10:21615800-21617000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
19	chr10:21616000-21616600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr10:21616000-21616600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr10:21616000-21616600	Enhancers	Cortex derived primary cultured neurospheres	brain
22	chr10:21616000-21616600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr10:21616000-21616800	Enhancers	HUES64 Cell Line	embryonic stem cell
24	chr10:21616000-21616800	Enhancers	iPS-15b Cell Line	embryonic stem cell
25	chr10:21616200-21616400	Enhancers	Fetal Muscle Leg	muscle
26	chr10:21616200-21616800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr10:21616200-21616800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
28	chr10:21616200-21616800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr10:21616200-21616800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr10:21616200-21617600	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links